phenytoin has been researched along with Experimental Mammary Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ROSENBLUM, I | 1 |
| STEIN, AA | 1 |
| Anisimov, VN | 2 |
| Ostroumova, MN | 1 |
| Dil'man, VM | 1 |
| Dilman, VM | 1 |
3 other studies available for phenytoin and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
PREFERENTIAL DISTRIBUTION OF DIPHENYLHYDANTOIN IN PRIMARY HUMAN BRAIN TUMORS.
Topics: Adenocarcinoma; Animals; Astrocytoma; Brain Neoplasms; Ependymoma; Humans; Mammary Neoplasms, Animal | 1963 |
[Inhibition of the blastomogenic effect of 7,12-dimethylbenz(a)anthracene in female rats by buformin, diphenin, a polypeptide pineal extract and L-DOPA].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Adenofibroma; Animals; Antineoplastic Agents; Benz | 1980 |
Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice.
Topics: Adenocarcinoma; Aging; Animals; Female; Leukemia, Experimental; Levodopa; Mammary Neoplasms, Experim | 1980 |